NCT04540094View on ClinicalTrials.gov

Feasibility of 5% Albumin Compared With Balanced Crystalloid, as Intravenous Fluid Resuscitation in Adult Patients With Sepsis, Presenting as an Emergency to Hospital

PHASE3CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

June 1, 2021

Primary Completion Date

September 12, 2022

Study Completion Date

April 30, 2023

Conditions
Sepsis
Interventions
DRUG

Human albumin

Any preparation of 5% Human Albumin Solution which has marketing authorisation in the UK to be used for this indication and is stocked by local hospital pharmacies at the participating sites, may be prescribed in this study

DRUG

Balanced crystalloid solution

"Any preparation of intravenous balanced crystalloid which has marketing authorisation in the UK to be used for this indication and is stocked by local hospital pharmacies at the participating sites, may be prescribed in this study."

Trial Locations (15)

Unknown

Aberdeen Royal Infirmary, Aberdeen

Addenbrookes Hospital, Cambridge

Derby Teaching Hosptial NHS Foundation Trust, Derby

Royal Infirmary Edinburgh, Edinburgh

Royal Devon and Exeter Hospital, Exeter

Glasgow Royal Infirmary, Glasgow

Queen Elizabeth University Hospital, Glasgow

St Johns, Livingston

St Georges Hospital, London

University College London Hospital, London

John Radcliffe Hospital, Oxford

Royal Alexandra Hospital, Paisley

Derriford Hospital Plymouth, Plymouth

Salford Royal NHS Foundation Trust, Salford

Musgrove Park Hospital, Taunton

All Listed Sponsors
lead

University of Edinburgh

OTHER